The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2010

Filed:

Jan. 12, 2007
Applicants:

Robert E. Mcdevitt, Freehold, NJ (US);

Yanfang LI, Lawrenceville, NJ (US);

Albert J. Robichaud, Ringoes, NJ (US);

Gavin D. Heffernan, Florence, NJ (US);

Richard D. Coghlan, Phoenixville, PA (US);

Ronald C. Bernotas, Royersford, PA (US);

Inventors:

Robert E. McDevitt, Freehold, NJ (US);

Yanfang Li, Lawrenceville, NJ (US);

Albert J. Robichaud, Ringoes, NJ (US);

Gavin D. Heffernan, Florence, NJ (US);

Richard D. Coghlan, Phoenixville, PA (US);

Ronald C. Bernotas, Royersford, PA (US);

Assignee:

Wyeth LLC, Madison, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 31/10 (2006.01); C07D 403/02 (2006.01); C07D 209/30 (2006.01); C07C 317/32 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to compounds of Formula I: which are modulators of the 5-hydroxtryptamine-6 and 5-hydroxytryptamine-2A receptors and which are inhibitors of norepinephrine reuptake. The compounds of the invention, and pharmaceutical composition thereof, are useful in the treatment of disorders related to or associated with the 5-hydroxytryptamine-6 and 5-hydroxtryptamine-2A receptors or with norepinephrine reuptake inhibition.


Find Patent Forward Citations

Loading…